Impact of COVID-19 Pandemic on Hepatopancreatobiliary Surgical Services in Singapore

Tan Tock Seng Hospital

Status: Completed

Conditions: COVID-19; Surgery

Treatments: Other: COVID-19 pandemic

Study type: Observational

Funder types: Other

Identifiers

NCT05572866

ttshhpb

Details and patient eligibility

About

This paper is intended to report our observational study in evaluating the impact of the COVID-19 pandemic on Tan Tock Seng Hospital hepatopancreatobiliary unit's surgical workload from January to June across 2019 to 2022, corresponding to the pre-pandemic baseline to its peak and the gradual normalization of hospital services as Singapore entered the transition phase to COVID-19 resilience.

Full description

This paper is intended to report our observational study in evaluating the impact of the COVID-19 pandemic on Tan Tock Seng Hospital hepatopancreatobiliary unit's surgical workload from January to June across 2019 to 2022, corresponding to the pre-pandemic baseline to its peak and the gradual normalization of hospital services as Singapore entered the transition phase to COVID-19 resilience.

A comparative audit of the unit's surgical workload for the months of January-June across 2019 to 2022, which corresponded to pre-COVID-19, the height of the pandemic, and a gradual normalization of surgical services. Operations performed by the unit were collected from the surgeons' electronic case logs. These operations were sorted based on the Singapore Ministry of Health's table of surgical procedures, which assigns charge codes to different procedures. The retrospective data across the 4 years were compared and analysed.

No patient contact or identifiers were retrieved, stored or disseminated and thus exempt from ethics board review.

Enrollment: 1,089 patients

Sex: All

Ages: 18 to 120 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• all patients who underwent gallbladder, hernia, liver or pancreas resection surgeries during the periods of January to June of 2019/2020/2021/2022.

Exclusion criteria

• anyone who does not fall within the inclusion criteria

Trial design

1,089 participants in 4 patient groups

2019

Description:

No intervention will be carried out. The sum total of surgeries carried out during 2019 will be audited to see how the COVID-19 pandemic has impacted the surgical volume.

Treatment:

Other: COVID-19 pandemic

2020

Description:

No intervention will be carried out. The sum total of surgeries carried out during 2020 will be audited to see how the COVID-19 pandemic has impacted the surgical volume.

Treatment:

Other: COVID-19 pandemic

2021

Description:

No intervention will be carried out. The sum total of surgeries carried out during 2021 will be audited to see how the COVID-19 pandemic has impacted the surgical volume.

Treatment:

Other: COVID-19 pandemic

2022

Description:

No intervention will be carried out. The sum total of surgeries carried out during 2022 will be audited to see how the COVID-19 pandemic has impacted the surgical volume.

Treatment:

Other: COVID-19 pandemic